A Ketone Ester Drink Lowers Human Ghrelin and Appetite

Brianna J Stubbs, Pete J Cox, Rhys D Evans, Malgorzata Cyranka, Kieran Clarke, Heidi de Wet, Brianna J Stubbs, Pete J Cox, Rhys D Evans, Malgorzata Cyranka, Kieran Clarke, Heidi de Wet

Abstract

Objective: The ketones d-β-hydroxybutyrate (BHB) and acetoacetate are elevated during prolonged fasting or during a "ketogenic" diet. Although weight loss on a ketogenic diet may be associated with decreased appetite and altered gut hormone levels, it is unknown whether such changes are caused by elevated blood ketones. This study investigated the effects of an exogenous ketone ester (KE) on appetite.

Methods: Following an overnight fast, subjects with normal weight (n = 15) consumed 1.9 kcal/kg of KE, or isocaloric dextrose (DEXT), in drinks matched for volume, taste, tonicity, and color. Blood samples were analyzed for BHB, glucose, insulin, ghrelin, glucagon-like peptide 1 (GLP-1), and peptide tyrosine tyrosine (PYY), and a three-measure visual analogue scale was used to measure hunger, fullness, and desire to eat.

Results: KE consumption increased blood BHB levels from 0.2 to 3.3 mM after 60 minutes. DEXT consumption increased plasma glucose levels between 30 and 60 minutes. Postprandial plasma insulin, ghrelin, GLP-1, and PYY levels were significantly lower 2 to 4 hours after KE consumption, compared with DEXT consumption. Temporally related to the observed suppression of ghrelin, reported hunger and desire to eat were also significantly suppressed 1.5 hours after consumption of KE, compared with consumption of DEXT.

Conclusions: Increased blood ketone levels may directly suppress appetite, as KE drinks lowered plasma ghrelin levels, perceived hunger, and desire to eat.

© 2017 The Authors. Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS).

Figures

Figure 1
Figure 1
(A) Schematic illustrating the study protocol. (B) Blood BHB kinetics following isocaloric KE and DEXT drinks in 15 subjects at rest. Values are means ± SEM. *P < 0.05 difference between KE and DEXT.
Figure 2
Figure 2
Changes in VAS responses from baseline, correlation between BHB and VAS score, and levels of plasma glucose, insulin, ghrelin, GLP‐1, and PYY following isocaloric KE and DEXT drinks in 15 subjects at rest. Panels 2D‐2F show data from the KE visit only: each point is one of the time series points between 30 and 240 minutes (seven time points) for each participant (n = 15), giving a total of 105 points. Values are means ± SEM. r = Pearson's r. *P < 0.05 difference between KE and DEXT; †P < 0.05 difference from baseline value.

References

    1. Dietrich MO, Horvath TL. Limitations in anti‐obesity drug development: the critical role of hunger‐promoting neurons. Nat Rev Drug Discov 2012;11:675‐691.
    1. Gibson AA, Seimon RV, Lee CM, et al. Do ketogenic diets really suppress appetite? A systematic review and meta‐analysis. Obes Rev 2015;16:64‐76.
    1. Sumithran P, Prendergast LA, Delbridge E, et al. Ketosis and appetite‐mediating nutrients and hormones after weight loss. Eur J Clin Nutr 2013;67:759‐764.
    1. Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE. Effects of a high‐protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr 2008;87:44‐55.
    1. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting. J Clin Invest 1967;46:1589‐1595.
    1. Paoli A, Bosco G, Camporesi EM, Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol 2015;6:27. doi:
    1. Arase K, Fisler JS, Shargill NS, York DA, Bray GA. Intracerebroventricular infusions of 3‐OHB and insulin in a rat model of dietary obesity. Am J Physiol 1988;255:R974‐R981.
    1. Laeger T, Pöhland R, Metges CC, Kuhla B. The ketone body β‐hydroxybutyric acid influences agouti‐related peptide expression via AMP‐activated protein kinase in hypothalamic GT1‐7 cells. J Endocrinol 2012;213:193‐203.
    1. Chearskul S, Delbridge E, Shulkes A, Proietto J, Kriketos A. Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. Am J Clin Nutr 2008;87:1238‐1246.
    1. Müller TD, Nogueiras R, Andermann ML, et al. Ghrelin. Mol Metab 2015;4:437‐460.
    1. le Roux CW, Neary NM, Halsey TJ, et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005;90:4521‐4524.
    1. Cox Pete J, Kirk T, Ashmore T, et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab 2016;24:256–268.
    1. Clarke K, Tchabanenko K, Pawlosky R, et al. Kinetics, safety and tolerability of (R)‐3‐hydroxybutyl (R)‐3‐hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 2012;63:401‐408.
    1. Stubbs RJ, Hughes DA, Johnstone AM, et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand‐held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000;84:405‐415.
    1. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289‐295.
    1. Mayer J. Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis. Ann N Y Acad Sci 1955;63:15‐43.
    1. Parker HE, Gribble FM, Reimann F. The role of gut endocrine cells in control of metabolism and appetite. Exp Physiol 2014;99:1116‐1120.
    1. Hall KD, Bemis T, Brychta R, et al. Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity. Cell Metab 2015;22:427‐436.
    1. Bayliss JA, Lemus MB, Stark R, et al. Ghrelin‐AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson's disease. J Neurosci 2016;36:3049‐3063.

Source: PubMed

3
Subskrybuj